Abstract
The effects of the new molecule ImH[trans-RuCl4(DMSO)Im] (NAMI-A), administered orally or intraperitoneally to adjuvant-arthritic rats or orally to mice bearing s.c. or i.m. implants of MCa mammary carcinoma, were studied. NAMI-A was not able to modify the progression of chronic inflammation in the complete Freund-adjuvant injected animals. Histology indicated a significant worsening of the inflammatory process, characterised by an increased infiltration of inflammatory cells, as well as by a remarkable deposition of connective tissue fibres around the blood vessels and alveolar walls. NAMI-A had no effect on primary i.m. implanted MCa mammary carcinoma growth and its lung metastasis formation, but significantly interfered with the cell cycle of primary tumor cells following bolus oral administration. On the contrary, NAMI-A caused a significant inhibition of lung metastasis accompanied by a dramatic deposition of connective tissue fibres around the primary tumor mass, when given as medicated food to mice implanted s.c. with MCa tumor. These data indicated that NAMI-A is well absorbed after oral administration although there is no connection between lung concentration and the antimetastatic activity. Conversely, the marked depo...Continue Reading
References
Mar 1, 1977·Agents and Actions·A BlackhamJ Westwick
May 1, 1992·Clinical & Experimental Metastasis·M J Duffy
Jul 1, 1992·Clinical & Experimental Metastasis·G SavaE Alessio
Feb 1, 1992·Anti-cancer Drugs·G SavaE Alessio
Oct 1, 1972·The Journal of Pharmacy and Pharmacology·Y MizushimaT Akimoto
Jun 1, 1966·Arthritis and Rheumatism·C A Winter, G W Nuss
Mar 30, 1995·Chemico-biological Interactions·G SavaE Alessio
Mar 1, 1994·Clinical & Experimental Metastasis·R GagliardiE Alessio
Jul 1, 1993·Cancer Treatment Reviews·D J Dodwell, A Howell
Sep 27, 1996·International Journal of Cancer. Journal International Du Cancer·G SavaS Garbisa
Aug 1, 1996·Anti-cancer Drugs·A BergamoG Sava
Jun 17, 1998·Clinical & Experimental Metastasis·G SavaG Mestroni
Jan 1, 1956·Proceedings of the Society for Experimental Biology and Medicine·C M PEARSON
Jan 1, 1995·Metal-based Drugs·M ColucciaE Alessio
Citations
Dec 22, 1999·Journal of Inorganic Biochemistry·I SeifrizC V Franco
Jun 1, 2009·Future Medicinal Chemistry·Simon M PagePaul D Barker
Nov 4, 2000·Expert Opinion on Investigational Drugs·D R Richardson, D B Lovejoy
May 23, 2014·Tissue & Cell·Boniface M KavoiStephen G Kiama
Jun 28, 2017·Chemical Society Reviews·Leli ZengZhe-Sheng Chen
Apr 16, 2002·British Journal of Cancer·A VaccaG Sava
Feb 5, 2010·Journal of Enzyme Inhibition and Medicinal Chemistry·Sreekanth ThotaErik De Clercq
Jul 1, 2014·Dalton Transactions : an International Journal of Inorganic Chemistry·Serena PillozziLuigi Messori
Nov 9, 2019·Chembiochem : a European Journal of Chemical Biology·Liam J StephensPhilip C Andrews
Apr 11, 2008·Dalton Transactions : an International Journal of Inorganic Chemistry·Venugopal RajendiranMallayan Palaniandavar
Mar 2, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Sethu RamakrishnanMallayan Palaniandavar
Nov 25, 2017·Chemical Society Reviews·Samuel M Meier-MenchesBernhard K Keppler
Nov 22, 2020·Mitochondrion·Sonia SilvestriAugusto Amici
Sep 4, 2007·Bioorganic & Medicinal Chemistry·Subhas S KarkiErik De Clercq
Dec 26, 2001·Chemical Reviews·M J ClarkeD R Frasca
Aug 30, 2008·Inorganic Chemistry·Isabella AsconeAgostina Congiu Castellano
Apr 29, 2021·Inorganic Chemistry·Pran Gobinda NandiAkshai Kumar
May 10, 2011·Organometallics·Jakob KljunIztok Turel
May 9, 2012·Inorganic Chemistry·Rangasamy LoganathanMallayan Palaniandavar
Jun 10, 2005·Journal of Medicinal Chemistry·Claudine ScolaroPaul J Dyson